Author:
Ueoka Ryuichi,Matsumoto Yoko,Ichihara Hideaki,Komizu Yuji
Reference57 articles.
1. Allen TM, Hansen CJ, Martin F, Redemann C, Yan YA (1991) Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. Biochem Biophys Acta 1066(1):29–36
2. Dinney CPN, Utsugi T, Fidler IJ, von Eschenbach AC, Killion JJ (1992) Immunotherapy of murine renal adenocarcinoma by systemic administration of liposomes containing the synthetic macrophage activator cgp 31362 or cgp 19835a in combination with interleukin 2 or –interferon. Cancer Res 52(5):1155–1161
3. Diomede L, Colotta F, Piovani B, Re F, Modest EJ, Salmona M (1993) Induction of apoptosis in human leukemic cells by the ether lipid 1-octadecyl-2-methyl-rac-glycero-3-phosphocholine. A possible basis for its selective action. Int J Cancer 53(1):124–130
4. Fendler JH (ed) (1982) Membrane mimetic chemistry. Wiley, New York
5. Fidler IJ, Lopez-Berestein G (eds) (1989) Liposomes in the therapy of infectious diseases and cancer. Alan R Liss, New York